Fitbit is launching its latest Apple Watch competitor, Versa 2, on September 15. The watch features Amazon’s Alexa, comes with a more powerful processor, tracks a user’s sleep and has a battery that lasts for five days. It will cost $200 with the option to upgrade to Fitbit Premium. (Reuters)

Thirty patients who took a Vertex Pharmaceuticals cystic fibrosis treatment have died, according to reports made by healthcare professionals to the Food and Drug Administration. The company said there is no direct evidence linking Symdeko to the deaths. FDA has not commented. (STAT)

Pinterest is helping to combat the spread of anti-vaccine content and misinformation on its platform. Instead of blocking searches related to vaccinations, it will direct those queries to posts from health groups such as the World Health Organization, the Centers for Disease Control and Prevention and others. (Associated Press)

The FDA will start to investigate impurities in generic drugs outside of angiotensin II receptor blockers, which are medicines for high blood pressure. The government organization has not shared what other drugs will be tested. The FDA began the inquiry after the generic version of Novartis’ Diovan was found to contain impurities that may cause cancer. (Reuters)

Want a sneak peak at our next issue? Here’s a preview of the September edition to tide you over through the Labor Day long weekend. And stay tuned for the rest of the feature content on September 4. (MM&M)